Co-Diagnostics, Inc.
Market Cap
$3.26M
P/E Ratio
-0.10
EPS
$-29.40
Dividend Yield
0.00%
52-Week Range
$2.36 — $46.50
Volume
80.20K
Avg Volume
737.89K
Beta
—
P/E (TTM)
-0.10
Forward P/E
—
PEG Ratio
-0.01
P/S (TTM)
6.15
P/B (TTM)
0.09
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.70%
ROA (TTM)
-0.72%
ROIC
—
Gross Margin
0.34%
Operating Margin
-69.96%
Net Margin
—
Debt/Equity
0.04
Current Ratio
3.81
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-1.01%
EPS Growth (5Y)
+4.21%
Sales Growth (3Y)
-0.63%
Sales Growth (5Y)
+68.85%
EPS Est (This Year)
$-12.15
EPS Est (Next Year)
$-12.00
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$9.06
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
1.12M
Float
1.04M
Free Float %
93.27%
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
NASDAQ
IPO Date
2017-07-12
Employees
132
CEO
Dwight H. Egan
Index Membership
—
Website
https://co-dx.com
Co-Diagnostics, Inc. (CODX) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $3.26M, a P/E ratio of -0.10, CODX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare CODX against other stocks using dozens of fundamental and technical filters.
Co-Diagnostics, Inc. (CODX) has a trailing twelve-month (TTM) P/E ratio of -0.10. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Co-Diagnostics, Inc. (CODX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Co-Diagnostics, Inc. (CODX) has a market capitalization of $3.26 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.